Friday, December 5, 2025
Search

Fulton Financial Corporation And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Via News Editorial Team

December 23, 2022

Fulton Financial Corporation  And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - Fulton Financial Corporation (FULT), Harmony Biosciences Holdings (HRMY), Halliburton Company (HAL) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Fulton Financial Corporation (FULT)

40.2% sales growth and 10.33% return on equity

Fulton Financial Corporation operates as a financial holding company that provides consumer and commercial banking products and services. It accepts various checking accounts and savings deposit products, certificates of deposit, and individual retirement accounts. The company also offers secured consumer loans, including home equity loans and lines of credit, automobile loans, personal lines of credit, and checking account overdraft protection; construction and jumbo residential mortgage loans; and commercial lending products comprising commercial real estate, commercial and industrial, and construction loans, as well as equipment lease financing loans. In addition, it provides letters of credit, cash management services, and traditional deposit products; and wealth management services, including investment management, trust, brokerage, insurance, and investment advisory services. Further, the company owns passive investments, as well as trust preferred securities; and sells various life insurance products. It provides its products and services through traditional financial center banking, as well as through a network of automated teller machines, telephone banking, mobile banking, and online banking. The company operated branches in Pennsylvania, Maryland, Delaware, New Jersey, and Virginia. Fulton Financial Corporation was incorporated in 1882 and is headquartered in Lancaster, Pennsylvania.

Earnings Per Share

As for profitability, Fulton Financial Corporation has a trailing twelve months EPS of $1.56.

PE Ratio

Fulton Financial Corporation has a trailing twelve months price to earnings ratio of 10.58. Meaning, the purchaser of the share is investing $10.58 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.33%.

Annual Top and Bottom Value

Fulton Financial Corporation stock was valued at $16.51 as of 19:22 EST. This is way lower than the $19.17 52-week peak and much higher than the $13.72 52-week low.

2. Harmony Biosciences Holdings (HRMY)

36.2% sales growth and 62.78% return on equity

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy in the United States. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.

Earnings per Share

Harmony Biosciences Holdings' trailing 12 month EPS is $2.43.

PE Ratio

Harmony Biosciences Holdings' trailing 12 months earnings to price ratio is 23.6 The purchaser of the shares is therefore investing $23.6 per dollar in annual earnings.

For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 62.78%.

Sales Growth

Harmony Biosciences Holdings's sales growth is 39.9% for the present quarter and 36.2% for the next.

Annual Top and Bottom Value

Harmony Biosciences Holdings stock was valued at $57.35 as of 19:22 EST. This is below its 52 week high of $62.08, and much higher than its 52 week low of $31.54.

Volume

Today's last reported volume for Harmony Biosciences Holdings is 91642 which is 80.37% below its average volume of 466857.

3. Halliburton Company (HAL)

31.9% sales growth and 26.35% return on equity

Halliburton Company supplies products and services for the global energy sector. The company operates in two main segments: Completion and production and drilling and evaluation. Production enhancement services include well bonding and capping, and cementing. It also offers well-boring and other services such as stimulation and sand controlling services. The segment offers electrical submersible pumps and artificial lift services. Drilling fluid systems, performance and additives, fluid control, solids control and testing equipment are all available in the Evaluation segment. This includes drilling system and service, drilling bits and services. These include open-hole logging, cased-hole, and slickline. Also, drill bits and other services such as fixed cutter bits, roller cone bits, hole enlargement and downhole tools, services and equipment. The segment offers cloud-based digital services on an open architecture to subsurface insight, integrated well construction and reservoir and production administration; as well as testing and subsea service, including acquisition, analysis, and optimization of reservoir information, project management, and integrated asset management. Halliburton Company was established in Houston, Texas in 1919.

Earnings Per Share

As for profitability, Halliburton Company has a trailing twelve months EPS of $-1.99.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 26.35%.

Growth Estimates Quarters

The company's growth estimates for the current quarter and the next is 80.6% and 80%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 38.8%, now sitting on 18.99B for the twelve trailing months.

Moving Average

Halliburton Company is worth more than its $50-day average of $35.44, and much higher than its $200-day average of $33.81.

4. Summit Financial Group (SMMF)

26% sales growth and 15.25% return on equity

Summit Financial Group, Inc. operates as a financial holding company for Summit Community Bank, Inc. that provides community banking and other financial services to individuals and businesses primarily in the Eastern Panhandle, Southern and North Central regions of West Virginia and the Northern, and Shenandoah Valley and Southwestern regions of Virginia, and the Central region of Kentucky. The company's community banking services include demand, savings, and time deposits; commercial, commercial real estate, construction and land development, residential real estate, and consumer loans; and mortgage warehouse lines of credit, as well as trust and wealth management, cash management, and insurance brokerage services. As of December 31, 2020, it operated through 43 banking offices. The company was incorporated in 1987 and is headquartered in Moorefield, West Virginia.

Earnings per Share

Summit Financial Group's trailing 12 months EPS is $3.87.

PE Ratio

Summit Financial Group's trailing 12-month price-earnings ratio is 6.59. The purchaser of the shares is required to invest $6.59 per dollar in annual earnings.

For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 15.25%.

Revenue growth

The twelve-month trailing revenue was 135.76M, an increase of 15% year-over-year.

Moving Average

Summit Financial Group's worth is below its 50-day moving average of $28.04 and under its 200-day moving average of $27.53.

Yearly Top and Bottom Value

Summit Financial Group's stock is valued at $25.50 at 19:22 EST, way under its 52-week high of $30.83 and higher than its 52-week low of $24.27.

5. Jack Henry & Associates (JKHY)

8.1% sales growth and 25.72% return on equity

Jack Henry & Associates, Inc. offers technology solutions and payment processing service primarily to financial institutions in the United States. It offers transaction and information processing services for banks, from small community institutions to large multi-billion dollar asset institutions, under the Jack Henry Banking name; core data processing for different credit unions under Symitar; and special financial performance, imaging, payments processing, information security, risk management, retail delivery and online solutions for financial institutions and corporate entities that fall under the ProfitStars branding. The company also offers a range of integrated apps that can process loan and deposit transactions. It also maintains centralized client/member data. SilverLake is a strong, commercial-oriented banking product. CIF 20/20 for banks, which provides a simple, parameter-driven system that banks can use. Core Director for banks, which offers a more cost-efficient, point-and-click system. Symitar, the company's business brand, offers Episys, which is robustly designed for credit cooperatives. CruiseNet is a more cost-efficient option designed specifically for credit unions. The company also offers electronic payments solutions, including the purchase and reselling of hardware systems such as servers, workstations and scanners; along with implementation and training. Jack Henry & Associates, Inc. is a Missouri-based company that was established in 1976.

Earnings per Share

Jack Henry & Associates' trailing 12 months EPS is $5.02.

PE Ratio

Jack Henry & Associates' trailing 12-month price-to-earnings ratio is 35.44. The purchaser of the shares is investing $35.44 per dollar in annual earnings.

For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability of a company relative to shareholders' equity, was 25.72%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Jack Henry & Associates's EBITDA is 6.75.

Sales Growth

Jack Henry & Associates has experienced a 4.6% increase in sales for the current quarter, and an 8.1% rise for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 8.4%, now sitting on 1.98B for the twelve trailing months.